Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Crossover, Drug-Drug Interaction Study Investigating the Effect of Clopidogrel on Dasabuvir in Healthy Volunteers

Next Previous
Trial Profile

A Randomized, Crossover, Drug-Drug Interaction Study Investigating the Effect of Clopidogrel on Dasabuvir in Healthy Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 02 May 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dasabuvir (Primary) ; Clopidogrel; Ritonavir
  • Indications Hepatitis C
  • Focus Pharmacokinetics

Most Recent Events

  • 26 Apr 2018 Results published in the Clinical Pharmacology and Therapeutics
  • 27 Mar 2018 New trial record
  • 24 Mar 2018 According to results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, the pharmacokinetic data was available for analysis on 25 Sep 2017.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top